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Macrophage differentiation and function are pivotal
for cell survival from infection and involve the pro-
cessing of microenvironmental signals that deter-
mine macrophage cell fate decisions to establish ap-
propriate inflammatory balance. NADPH oxidase 2
(Nox2)–deficient chronic granulomatous disease
(CGD) mice that lack the gp91phox (gp91phox/) cat-
alytic subunit show high mortality rates compared
with wild-type mice when challenged by infection
with Listeria monocytogenes (Lm), whereas p47phox-
deficient (p47phox/) CGD mice show survival rates
that are similar to those of wild-type mice. We dem-
onstrate that such survival results from a skewedmac-
rophage differentiation program in p47phox/ mice
that favors the production of higher levels of alterna-
tively activated macrophages (AAMacs) compared
with levels of either wild-type or gp91phox/ mice.
Furthermore, the adoptive transfer of AAMacs from
p47phox/mice can rescue gp91phox/mice during
primary Lm infection. Key features of the protective
function provided by p47phox/ AAMacs against Lm
infection are enhanced production of IL-1 and kill-
ing of Lm. Molecular analysis of this process indicates
that p47phox/macrophages are hyperresponsive to
IL-4 and show higher Stat6 phosphorylation levels
and signaling coupled to downstream activation of
AAMac transcripts in response to IL-4 stimulation.
Notably, restoring p47phox protein expression levels re-
verts the p47phox-dependent AAMac phenotype. Our re-
sults indicate that p47phox is a previously unrecognized
regulator for IL-4 signaling pathways that are importantfor macrophage cell fate choice. (Am J Pathol 2012, 180:
1049–1058; DOI: 10.1016/j.ajpath.2011.11.019)
Activated macrophages maintain inflammatory balance
during tissue damage, stress, and immune reactions,
and thereby preserve local homeostasis. Inflammation is
a protective host response to injury caused by patholog-
ical and physiological insults such as microbial infection
and tissue damage.1 It is a biphasic process; involving
both vascular and cellular responses, and is triggered by
irritants within the local tissue milieu. Macrophages are
major innate immune cellular respondents to pathological
and physiological environmental signals. Depending on
the signal(s) received, macrophages differentiate along
classical versus alternative activation pathways. Using
this linear categorization, classically activated macro-
phages are typically defined immunologically as pro-in-
flammatory mediators, whereas the diverse population of
alternatively activated macrophages (AAMac) are classi-
fied as anti-inflammatory.2 However, more recent classi-
fication of macrophages based on their homeostatic and
regulatory roles such as host defense, wound healing,
and immune regulation encompasses their homeostatic
as well as immunological function.3,4 Various innate or
adaptive signals initiate CD4 T-cell activation and dif-
ferentiation into polarized T helper 1 (TH1) and TH2 effec-
tors that secrete cytokines such as interferon (IFN)– and
interleukin (IL)–4, respectively. In turn, IFN- drives clas-
sical macrophage activation, whereas IL-4 drives alter-
native macrophage activation during adaptive immune
responses.5
We recently reported that p47phox/ mice,6 a model
of the human immunodeficiency chronic granulomatous
disease (CGD), develop AAMac-driven active chronic
inflammation7 characterized by systemic exaggerated
chitinase-like Ym1/Ym2 protein8 secretion and progres-
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recognized as an organizing adaptor protein for multicom-
ponent NADPH oxidase (Nox)2 holoenzyme–dependent
superoxide generation.9,10 Mutations in the genes for
p47phox and the membrane-associated catalytic gp91phox/
Nox2 subunit comprise the major autosomal recessive and
X-linked, respectively, forms of CGD.11–13 Phagocytes from
p47phox/6 and gp91phox/14 mice are devoid of
NADPH oxidase–dependent reactive oxygen species
(ROS) production. In addition, similar to human CGD
patients, p47phox/ 6 and gp91phox/14 mice develop
CGD-like lesions, including those of systemic infection,
granulomatous inflammation, and active chronic hyperin-
flammatory diseases.13,15,16
Interestingly p47phox/ mice spontaneously develop
sterile progressive crystalline macrophage pneumonia in
a pulmonary niche that also contains high levels of IL-12
and TH1, TH2, and TH17 cytokines.
7 These findings reveal
that the sterile spontaneous active chronic inflammation
in the p47phox/ mice is noncanonical, and thereby in-
dicate that there is a more complex basis for the ob-
served aberrant p47phox/ AAMac-mediated inflamma-
tion that is likely to involve contributions from both
macrophage intrinsic factors and the inflammatory niche
in p47phox-deficient mice.
In this study, we explored the signaling pathways me-
diating p47phox/ macrophage default to an AAMac
phenotype during primary Lm infection. Here we show
that AAMacs from p47phox/ mice provide a protective
function against Listeria monocytogenes (Lm) infection. A
key finding is that STAT6 molecular signaling is upregu-
lated and transcription of phenotypic AAMac transcripts
is enhanced in p47phox/ macrophages because the
macrophages are hyperresponsive to IL-4 stimulation.
Materials and Methods
Mice
NADPH oxidase p47phox-deficient (p47phox/) mice
have previously been described.6 The backcrossing of
14 generations with wild-type (WT) C57BL/6NTac gener-
ated congenic p47phox/ mice on a C57BL/6NTac
background. Both congenic p47phox/ and WT control
mice (C57BL/6NTac) were obtained from Taconic Farms
(Hudson, NY).The p47phox/ mice were housed in asep-
tic conditions and given water containing Bactrim (0.13
mg/mL trimethoprim and 0.67 mg/mL sulfamethoxazole;
Actiatis MidAtlantic, Columbia, MD). gp91phox//Nox2/
B6.129S6-Cybbtm1Din/J mice14 were obtained from the
Jackson Laboratory (Bar Harbor, ME). Nox1/17 mice
were a generous gift from Dr. Chihiro Yabe-Nishimura
(Kyoto Prefectural University of Medicine, Kyoto Japan). All
mice were 6 to 8 weeks of age. This study (permit no. ASP
LHD 11) was reviewed and approved by the Animal Care
and Use Committee of the National Institute of Allergy
and Infectious Diseases of the National Institutes of
Health (Public Health Service Assurance A4149-01). The
study was performed in strict accordance with the rec-
ommendations in the Guide for the Care and Use ofLaboratory Animals of the National Institutes of Health/
National Institute of Allergy and Infectious Diseases.
Bacteria and Reagents
Recombinant Lm (rLM-OVA)18 strain 10403S expressing
ovalbumin was a generous gift from Dr. Hao Shen (Univer-
sity of Pennsylvania, School of Medicine, Philadelphia, PA).
Lm was subcultured on Difco Brain Heart Infusion Agar
(BHI; BD, Sparks, MD). Polyethylene glycol SOD (PEG-
SOD) was purchased from Sigma-Aldrich (St. Louis, MO),
and diphenylene iodonium (DPI) was purchased from Cal-
biochem (EMD Chemicals, Inc., Gibbstown, NJ).
Histopathology and Immunohistochemistry
Tissue sections (3 to 4 m) from formalin-fixed paraffin-
embedded tissues were stained with hematoxylin and
eosin (H&E) and examined for routine histopathology.
Similar unstained sections were used for immunofluores-
cence. For immunofluorescence, slides were deparaf-
finized in Xylene and rehydrated through graded concen-
trations of ethanol. A rabbit polyclonal antibody against
YM1/YM2 proteins8 was incubated on the tissue sections
at a dilution of 1:250 for 60 minutes at room temperature.
The bound YM1/YM2 antibody was detected using a
biotinylated anti-rabbit secondary antibody (Vector Labs,
Burlingame, CA), followed by streptavidin conjugated
with Alexa Fluor 594 (Invitrogen, Carlsbad, CA). For de-
tecting murine macrophage mannose receptor (MMR),
sections were incubated with a goat polyclonal antibody
against MMR (R&D Systems, Inc., Minneapolis, MN) at a
dilution of 1:100 for 60 minutes at room temperature.
Bound antibody was detected using a biotinylated anti-
goat secondary antibody (Vector Labs), followed by
streptavidin conjugated with Alexa Fluor 594 (Invitrogen).
Nuclei were stained with DAPI, and sections were
mounted with ProLong Gold anti-fade mounting medium
(Invitrogen).
Infection of Mice and Determination of Bacterial
Load
Overnight rLM-OVA cultures were serially diluted in PBS
to the desired dose and injected i.v. into the lateral tail
vein or i.p. into the peritoneal cavity of mice as indicated.
Inoculates were plated in sterile PBS on BHI agar (BD) to
verify dose. Bactrim prophylaxis was discontinued 1
week before infection. Mice were infected with 5  104
CFU (0.1 LD50) by i. v. injection. Bacterial loads were
determined by plating 10-fold serials dilutions of organ
homogenates in sterile PBS on BHI agar (BD).
Macrophage Adoptive Transfer
Donor p47phox/ mice received 5  104 CFU (0.1 LD50)
Lm. in 1 mL of PBS by i.p. injection, or 1 mL of 3% w/v of
thioglycolate 3 days before macrophage harvest. Ten
million p47phox/ inflammatory macrophages were i. v.
injected in 10 gp91phox/ recipient mice 1 day before
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gp91phox/ mice received 100 L of PBS by i.v. injec-
tion.
Intracellular Stain and Flow-Cytometric Analysis
Spleens from C57BL/6 WT, p47phox/ and gp91phox/
mice infected by 0.1 LD50 rLM-OVA were aseptically
removed and passed though a nylon mesh screen. Red
blood cells were lysed with ACK lysing medium (Lonza,
Walkersville, MD). Splenocytes (5  106 cells/mL) were
resuspended in IMDM complete: IMDM (Gibco/Invitro-
gen Corp, Carlsbad, CA) containing 10% fetal bovine
serum (Hyclone Laboratories, Logan, UT), 2.0 mmol/L
L-glutamine (Hyclone), 50 mol/L -mercaptoethanol
(Sigma Aldrich, St. Louis, MO), and 100 units/mL of pen-
icillin and streptomycin 10 units/mL (Gibco/Invitrogen),
and incubated with 10 g/mL OVA257–264 or OVA323–339
peptides (synthesized by NIAID Research Technologies
Branch- Peptide Synthesis and Analysis Unit, Bethesda,
MD). A 1-g/mL quantity of Golgistop (BD Pharmingen)
was added for the final 2 hours of culture. After 5 hours,
cells were stained with fluorochrome-labeled antibodies
(anti-CD4, anti-CD8, and anti-IL-4; BD Pharmingen, San
Diego, CA) using the Cytofix/Cytoperm Kit (BD Pharmin-
gen) according to the manufacturer’s instructions.
Splenocytes were analyzed on a FACS Canto (BD Bio-
science, San Jose, CA), and data were analyzed using
FlowJo (Tree Star, Ashland, OR).
Macrophage Preparation and Culture
Peritoneal macrophages were harvested from thioglyco-
late (Sigma Aldrich, St. Louis, MO)–stimulated mice as
previously described.7 Mice received 2 mL 3% w/v thio-
glycolate i.p. 3 days before macrophage harvest. Ap-
proximately 1  106 cells per sample were seeded into
24-well plates in volume of 1 mL. After a 3-hour incuba-
tion, the nonadherent cells were removed by washing
with PBS. The adherent cells were incubated in DMEM
(Gibco/Invitrogen) supplemented with 10% fetal bovine
serum (ATCC, Manassas,VA), and stimulated as indi-
cated.
Bone Marrow–Derived Macrophages
Briefly, bone marrow was flushed with PBS, resuspended
in 1 mL of ACK lysing medium (Lonza), and incubated at
room temperature for 5 minutes to eliminate red blood
cells. The single-cell suspension was filtered though a
40-m cell strainer (BD Falcon/BD Biosciences, San
Jose, CA), re-suspended at a density of 3  106/mL in
complete DMEM (Gibco/Invitrogen) supplemented with
10% fetal bovine serum (ATCC) and 10 ng/mL GM-CSF
(R&D Systems), and then plated and incubated in a 5%
CO2 incubator for 5 days. Nonadherent cells were de-
canted, and the remaining adherent cells were washed
with fresh medium and stimulated as indicated.Lm-Infected Macrophage Isolation and Culture
Mice received 5 104 CFU (0.1 LD50) Lm. in 1 mL of PBS
by i.p. injection 7 days before macrophage harvest, as
described above.
In Vitro Lm-Killing Assay
Bone marrow–derived macrophages were plated on a
24-well plate at 5  105 cells per well and cultured with
complete DMEM alone or supplemented with IL-4 (1000
U/mL), heat-killed Lm (HKL; 1  105 CFU/mL), or lipo-
polysaccharide (100 ng/mL, InvivoGen, San Diego, CA)
plus IFN- (50 U/mL, R&D Systems) for 24 hours. After
washing with PBS, cells were inoculated with 5  105
CFU/mL of Lm in 1 mL of RPMI 1640 (Gibco/Invitrogen)
plus 10% normal mouse serum without antibiotics for 30
minutes. The cells were then incubated with RPMI 1640
plus 10% FCS and 5 g/mL Gentamicin (Sigma Aldrich)
for 30 minutes to kill extracellular bacteria, washed with
PBS, and incubated with RPMI 1640 plus 10% fetal calf
serum for 5.5 hours (time 6 hours). After 6 hours, the cells
were washed and lysed with 0.05% Triton X-100 (Sigma
Aldrich). At the 30-minute time point, time 0 cells were
washed and lysed with 1 mL of 0.05% Triton X-100
(Sigma Aldrich). The lysates were plated on BHI agar
(BD) overnight, and Lm killing was determined by count-
ing the number of CFU per well.
Virus Production and Transduction
VSV-G–pseudotyped lentiviral–human p47phox and e-green
fluorescent protein (eGFP) were generated by transient co-
transfection of the specific transfer vector plasmid with
the three packaging plasmids (pMDLg/pRRE, the gag-
pol plasmid; pRSV-Rev, a Rev-expressing plasmid; and
pMD.G, a VSV-G envelope–expressing plasmid) into
293T cells (ATCC) as described previously.19 Lentiviral
vector supernatant was filtered, concentrated by ultra-
centrifugation (43,000 g for 3 hours), and aliquots were
stored at 70°C. For transient expression, 20 L of the
concentrated virus was added to the cell culture media,
followed by a 30-minute centrifugation (2500 rpm) for 3
consecutive days to enhance the transduction. Trans-
duction was confirmed by microscopic and flow-cyto-
metric detection of eGFP expression using FACS (BD
Bioscience).
Quantitative Real-Time PCR
Total RNA was extracted by using the RNeasy Mini Kit
(Qiagen, Valencia, CA) according to the manufacturer’s
instructions. Quantitative real-time PCR (qPCR) was per-
formed with the 7500 Real Time PCR System (Applied
Biosystems, Foster City, CA) and performed with 1 ng of
RNA samples and specific Gene Expression Assay (Ap-
plied Biosystems) using the TaqMan RNA-to-CT 1-Step
Kit (Applied Biosystems). The Gene Expression Assays
for YM1, Arg1, GAPDH, PKG1, and RPS29 were pur-
chased from Applied Biosystems. The relative change in
gene expression was calculated by the  Ct method
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RPS29 as a reference.
Immunoblotting
Cell lysates were prepared in M-PER Buffer (Pierce Bio-
technology, Rockford, IL) supplemented with Halt Pro-
tease Inhibitor Cocktail and Phosphatase Inhibitor Cock-
tail (Pierce Biotechnology). The protein concentrations
were determined by the Bradford assay. Proteins were
resolved by NuPage 4 to 12% Bis-Tris Gel (Invitrogen,
Carlsbad, CA) and transferred to nitrocellulose mem-
branes by iBlot Gel Transfer (Invitrogen). Immunoblotting
analyses were performed by SNAPid system (Millipore,
Billerica, MA). Immunocomplexes were reacted with
Western Blotting Reaction Reagent (GE Healthcare, Pis-
cataway, NJ). Proteins were then visualized by exposed
to HyBlot CL film (Denville Scientifics, Metuchen, NJ).
Scanned images were analyzed by ImageJ20 for the rel-
ative protein quantification, anti–-actin monoclonal anti-
body (Sigma), anti-p47phox polyclonal antibody (Milli-
pore, Billerica, MA), anti–ECF-L monoclonal antibody
(R&D Systems), anti-Arg1 monoclonal antibody (BD), an-
ti-phosphorylated Stat6 (pY641) polyclonal antibody (BD)
and anti-Stat6 polyclonal antibody (BD) were used as
primary antibodies. The secondary antibodies, ECL
Mouse IgG, HRP-Linked Whole antibody (from sheep),
ECL Rabbit IgG, HRP-Linked Whole antibody (from don-
key) and ECL Rat IgG, HRP-Linked Whole antibody (from
goat) were purchased from GE Healthcare.
Statistical Analysis
Multigroup test analysis using repeated-measures
analysis of variance with the Tukey, Bonferroni, or New-
man–Keuls post test using a value of   0.05 for the
99.9% confidence interval was performed for the real-
time PCR and the severity score analyses. Multigroup
test analysis using repeated-measures analysis of vari-
ance with the Tukey, Bonferroni or Newman–Keuls post
test, and two-way analysis of variance with a Bonferroni
post test using a value of   0.001 for the 99.9% con-
fidence interval was performed for the in vitro killing as-
says. Differences between gp91phox/ recipient mice in
the survival analysis were determined by Mantel–Cox
log-rank test and the log-rank test for trends (Prism 5;
GraphPad Software, San Diego, CA).
Results
p47phox/ Macrophages Discriminate Classical
Versus Alternative Activation Signals
We previously demonstrated that thioglycolate-elicited in-
flammatory macrophages from p47phox/ mice discrim-
inate classical versus alternative macrophage activation
signals in vitro, and that the inflammatory macrophages
from the peritoneal cavities of p47phox/ mice also se-
crete Ym1 protein ex vivo.7 Using IL-4 to simulate alter-
native activation or IFN- in combination with heat-killedLm (HKL/) or LPS (LPS/) to simulate classical activa-
tion, we observed that, similar to inflammatory macro-
phages, bone marrow–derived p47phox/ macro-
phages (BMMacs) also discriminate classical versus
alternative macrophage activation signals in vitro (Fig-
ure 1). Using real-time PCR quantification, we found that
whereas IL-4 stimulated p47phox/ BMMacs express
more Ym1 than WT or NADPH oxidase 2 catalytic sub-
unit–deficient gp91phox/ BMMacs, Ym1 gene expres-
sion was not detected in WT, p47phox/ or gp91phox/
BMMacs treated with classical pathway stimuli (Figure
1A). We also found that, in response to IL-4 as well as
classical pathway stimuli, transcription for the classical
activation marker iNos was similar in BMMacs from each
genotype (Figure 1A).
Protein analysis revealed that neither resting WT nor
p47phox/ BMMacs express Ym1 protein in the absence
of in vitro stimulation. However, similar to inflammatory
p47phox/ macrophages, IL-4–stimulated p47phox/
BMMacs express more Ym1 protein than similarly treated
Figure 1. p47phox/ macrophages discriminate activation signal in vitro.
Bone marrow–derived macrophages were stimulated overnight with 1000
units/mL IL-4, heat-killed Lm (HKL/ or LPS/). A: Real-time PCR quantifi-
cation of Ym1 and iNos. Values are relative to expression of the gene
encoding RPS29. Data represent three independent experiments including
three to four of each genotype per experiment. *P 0.05. B: Total cell lysates
from BMMacs stimulated overnight with IL-4 or LPS/ were blotted with
anti-Ym1 or anti–-actin. Results are representative of two independent
experiments including three of each genotype per experiment.WT BMMacs (Figure 1B). These findings indicated that
ene enc
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cal versus alternative macrophage activation signals,
IL-4 stimulation induced a more robust AAMac pheno-
type in p47phox/ macrophages.
p47phox Protein Is Essential for Attenuating
IL-4–Dependent Alternative Macrophage Activation
In macrophages, IL-4 induced STAT6 activation, which
initiated transcription of specific alternative macrophage
activation genes such as Ym1, arginase 1 (Arg1), and
FIZZ1.5 To further discriminate a role for p47phox protein
in regulating macrophage cell fate decisions, we next
assessed IL-4–induced STAT6 activation, and transcrip-
tional changes in STAT6-regulated AAMac target genes
in inflammatory macrophages. Relative to either WT or
gp91phox/ macrophages, STAT6 phosphorylation was
significantly enhanced in p47phox/ macrophages that
were treated with 10 and 50 units of IL-4 (Figure 2A). In
contrast, there was no difference in STAT6 phosphoryla-
tion in WT, p47phox/, or gp91phox/macrophages that
were stimulated with a saturating dose of 5000 units of
IL-4. Consistent with the finding that Ym1 transcripts are
upregulated in IL-4–stimulated p47phox/ BMMacs rel-
ative to similarly treated WT macrophages (Figure 1),
transcripts encoding Ym1, Arg1, and FIZZ1 were also
upregulated in IL-4–stimulated p47phox/ inflammatory
macrophages (Figure 2B). Interestingly, IL-4–induced
transcripts for Ym1, Arg1, and FIZZ1 were similar in WT
and gp91phox/ inflammatory macrophages (Figure
2B). Furthermore, unlike WT or gp91phox/ macro-
phages, transcription of FIZZ1 was significantly upregu-
lated in response to 10 units of IL-4 stimulation, and
Figure 2. p47phox protein attenuates IL-4 signaling in macrophages indepen
ylation in inflammatory macrophages from each genotype stimulated with
independent experiments are shown. B: Real-time PCR analysis of Arg1, Ym
with IL-4 for 18 hours as indicated. Values are relative to expression of the g
of each genotype per experiment. *P  0.05.transcripts for FIZZ1, Ym1, and Arg1 were significantlyupregulated in response to 50 units of IL-4 stimulation in
p47phox/macrophages (Figure 2B). These data clearly
demonstrate that, unlike WT or gp91phox/ macro-
phages, p47phox/ macrophages are hyperresponsive
to IL-4 stimulation, which indicates that the skewed
AAMac phenotype is cell intrinsic and due to the loss of
p47phox protein expression.
Notably, IL-4 did not trigger STAT6 hyperphospho-
rylation or enhance transcription of target AAMac
genes in gp91phox/ macrophages in vitro (Figure 2).
We also found that Ym1 protein expression was similar
in IL-4–stimulated macrophages from WT mice, and
Nox catalytic subunit gp91phox and Nox117-deficient
mice (see Supplemental Figure S1A at http://ajp.
amjpathol.org). Furthermore, scavenging endogenous
superoxide, using the membrane-permeable ROS
scavenger polyethylene glycol–superoxide dismutase
(PEG-SOD), which converts superoxide into hydrogen
peroxide (see Supplemental Figure S1B at http://
ajp.amjpathol.org), and the selective Nox inhibitor di-
phenylene iodonium (DPI;9 see Supplemental Figure
S1C at http://ajp.amjpathol.org) did not enhance IL-4–
induced STAT6 activation in inflammatory WT macro-
phages. These findings further support the essential
role for p47phox protein rather that gp91phox/Nox2 en-
zymatic activity for regulating IL-4–dependent alterna-
tive macrophage activation.
p47phox/–Dependent AAMac Phenotype Is
Rescued by Restoring p47phox Expression
To assess the significance of the p47phox protein for
modulating IL-4–dependent alterative macrophage acti-
the gp91phox catalytic subunit. A: Immunoblot analysis of STAT6 phosphor-
20 minutes as indicated. Results of one representative experiment of three
ZZ1 mRNA from inflammatory macrophages from each genotype stimulated
oding RPS29. Data represent three independent experiments including threedent of
IL-4 for
, and FIvation, we used a retroviral vector that expresses human
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murine macrophages. Compared with p47phox/ macro-
phages transfected with a control vector that expresses
green fluorescent protein, when p47phox protein expression
was re-established in IL-4–stimulated p47phox/ macro-
phages, STAT6 phosphorylation was attenuated (Figure
3A), and Ym1 and Arg1 protein expression were signifi-
cantly reduced (Figure 3B). Moreover, STAT6 activation
was also attenuated (Figure 3A), and Ym1 and Arg1
protein expression were reduced (Figure 3B) in WT mac-
rophages where p47phox is overexpressed. These data
support that p47phox protein is necessary and sufficient to
revert the WT macrophage phenotype.
Figure 3. Restoring p47phox protein attenuates signaling downstream of the
IL-4R. Immunoblot analysis of p47phox/ bone marrow–derived macro-
phages (BMMacs) expressing human p47phox (hNCF1). BMMacs were trans-
duced by viral infection with hNCF1 or control vector (rGFP). A: Immunoblot
analysis of IL-4–stimulated STAT6 phosphorylation. Quantification relative to
total STAT6 is indicated. B: Immunoblot analysis of IL-4 stimulated Ym1 and
ArgI expression. Results are representative of three independent experiments
including three of each genotype per experiment.
Figure 4. Enhanced Lm killing by p47phox/ AAMacs. Mice were infected w
A: Lm peritoneal bacterial burdens 3 days postinfection. Data are mean (
genotype. B: In vitro Lm killing by WT and p47phox/ BMMacs primed ove
of seven independent experiments with pooled cells from three of each geno
5overnight as indicated, before infection with 5  10 CFU Lm. Data are mean (
p47phox/ mice/experiment. **P  0.001.Enhanced Lm Killing by IL-4–Primed p47phox/
Macrophages Is Mediated by IL-1
To investigate p47phox/ macrophage responsiveness
in vivo, we also assessed macrophage differentiation in
p47phox/ and catalytic subunit gp91phox/ CGD mice
in the context of Lm infection.21 Lm, is an intracellular
bacterium that induces a robust innate immune response
including triggering macrophage NADPH oxidase and
nitric oxide–dependent microbial killing; as well as CD4
TH1 and CD8
 T lymphocyte IFN-–mediated adaptive
immunity.22 Thus, Lm infection typically triggers classical
macrophage activation and therefore is not expected to
induce an AAMac phenotype. We inoculated Lm i.p. into
WT, gp91phox/, and p47phox/ mice and found that
the Lm bacterial burdens were significantly lower in
p47phox/ peritoneal exudate cells than gp91phox/
peritoneal exudate cells 3 days postinfection (Figure 4A),
which suggests that Lm elicited p47phox/ macro-
phages have enhanced Lm killing. To further investigate
the mechanism for the lower Lm bacterial load in
p47phox/ Lm elicited p47phox/ macrophages, we
next performed in vitro Lm-killing assays using BMMacs
primed with IFN- and heat-killed Lm (HKL) to simulate
classical macrophage activation, or BMMacs prime with
IL-4 to simulate alternative macrophage activation. As
expected, we found that the classical pathway induction
improved Lm killing in both WT and p47phox/ macro-
phages. However, we also found that there was signifi-
cantly more killing of Lm in the IL-4–primed p47phox/
macrophages but not in IL-4–primed WT macrophages
(Figure 4B).
We previously reported that although IL-4 induces pri-
marily anti-inflammatory cytokine secretion in WT and
p47phox/ macrophages, both classically and alterna-
tively activated p47phox/ macrophages hypersecrete
IL-1,7 which enhances resistance against Lm infec-
tion.23 Although the mechanism for the enhanced IL-1
secretion is not yet defined, we speculated that this pro-
inflammatory cytokine secretion might be the basis for the
enhanced Lm killing in IL-4–primed p47phox/ macro-
104 CFU of Lm by i.p. injection. Tissues were harvested 3 days postinfection.
for six individual mice from two separate experiments with three of each
s indicated, before infection with 5  105 CFU Lm. Data are mean ( SEM)
periment. **P  0.001. C: In vitro Lm killing by p47phox/ BMMacs primedith 5 
SEM)
rnight a
type/ex SEM) of three independent experiments with pooled cells from three
91
s are rep
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the in vitro killing by IL-4–treated p47phox/ macro-
phages that were also treated with anti–IL-1 antibody
before Lm infection was similar to that in the untreated
p47phox/ macrophage population (Figure 4C). Thus,
blocking the IL-1 activity abolishes the enhanced in vitro
Lm killing demonstrated by IL-4–biased p47phox/mac-
rophages, thereby supporting that by secreting IL-1 the
p47phox/ macrophages do kill intracellular Lm better
than unprimed p47phox/ macrophages.
p47phox/ Mice Survive Primary Lm Infection
and Show Less Severe Tissue Pathology
We next investigated whether p47phox/ AAMacs would
convey protection against Lm in vivo. Similar to what we
recently reported,7 p47phox/ and gp91phox/ mice
developed progressive crystalline macrophage pneumo-
nia 3 days after Lm infection (Figure 5). This pneumonia
was more severe in p47phox/ mice when compared
with gp91phox/ mice (Figure 5), and was characterized
by intracellular and extracellular accumulation of YM1/
YM2-positive crystals (Figure 6A) and intracellular mac-
rophage mannose receptor (Figure 6B), and by in-
creased numbers of alveolar macrophages and
multinucleated giant cells. The spleens of gp91phox/
and p47phox/mice were markedly enlarged when com-
Figure 5. H&E-stained tissue sections from gp91phox/ (A–C), p47phox/
tissue types. Changes in the liver and spleen of gp91phox/ mice at 3 days
show evidence of tissue necrosis (original magnification, 200). Lungs of gp
giant cells and crystalline pneumonia (original magnification, 400). Resultpared with Lm-infected WT mice, and the white pulp wasexpanded by infiltrates of macrophages admixed with
variable numbers of neutrophils (Figure 5). Splenic in-
flammation and disruption of the micro-architecture was
more extensive and severe in Lm-infected gp91phox/
mice relative to Lm-infected WT and p47phox/ mice 3
days postinfection. In addition, the spleens of Lm-in-
fected gp91phox/ mice contained multiple areas of pa-
renchymal necrosis, which were not evident in either Lm-
infected WT or p47phox/ mice. Although spleens from
Lm-infected p47phox/ mice were abnormal, livers from
these animals were generally unremarkable and con-
tained small scattered foci of inflammation (Figure 5),
comparable to what was seen in livers of Lm-infected WT
mice. In contrast to the mild changes observed in the
livers of Lm-infected p47phox/ and WT mice, livers from
Lm-infected gp91phox/ showed multiple, often exten-
sive areas of inflammation and necrosis. In gp91phox/
mice, this severe inflammation and necrosis in both the
spleen and liver at 3 days after Lm infection was as-
sociated with reduced survival (75% versus 100% in
p47phox/ mice).
Our in vitro investigations reveal that p47phox/
macrophages are hyperresponsive to IL-4 stimulation
(Figure 2). Therefore, to determine whether the rapid
and pronounced AAMac accumulation in Lm-infected
p47phox/ tissues was due to aberrant cytokine secre-
tion, we used flow cytometry to assess IL-4 protein ex-
and WT (G–I) mice showing differences in severity of pathology in multiple
infection were more severe than in those of p47phox/ and WT mice and
/ and p47phox/ contained infiltrates of macrophages and multinucleated
resentative of five each genotype examined.(D–F),
post-Lm
phoxpression in T cells from Lm-infected mice. As shown in
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AJP March 2012, Vol. 180, No. 3Figure 6C, the percentage of IL-4–positive CD4 lym-
phocytes in the spleens of Lm-infected p47phox/ mice
was marginally higher than similarly treated WT T lym-
phocytes, at 9.5% and 5.9% respectively (P  0.043).
Furthermore, the difference in the percentage of IL-4–
positive CD8 lymphocytes in the Lm-infected spleens of
WT and p47phox/ as well as WT and gp91phox/ mice
was not statistically significant (P 0.057 and P 0.075,
respectively). Thus, these findings indicate that the ex-
aggerated AAMac phenotype in the Lm-infected
p47phox/ mice was not driven solely by excessive
IL-4 secretion.
Adoptive Transfer of AAMacs from p47phox/
Mice into Lm-Infected gp91phox/ Mice
Reduces Tissue Pathology and Enhances
Survival
The finding that p47phox/ macrophages differentiate
into an AAMac phenotype spontaneously in sterile inflam-
matory lesions7 and during acute Lm infection suggest
that selective differentiation along the alternative activa-
tion pathway may be advantageous in p47phox/ mice.
To discern whether this is the case in the context of in vivo
Lm infection, we adoptively transferred Lm or thioglyco-
late elicited inflammatory p47phox/ macrophages (see
Materials and Methods) into gp91phox/ mice before Lm
infection. All of the recipients of p47phox/macrophages
survived primary Lm infection, compared with 60% of
gp91phox/ mice that were sham injected with PBS be-
fore Lm infection (Figure 7A). Moreover, gp91phox/ re-
cipients of p47phox/ AAMacs showed a reduction in the
Figure
p47phox
the cyto
Results
infected
peptides
the final
IL-4 was
from twextent and severity of inflammation and necrosis in boththe spleen and liver (Figure 6B). Collectively these ob-
servations suggest that AAMacs in Lm-infected
p47phox/ mice function to moderate Lm-induced dis-
ease pathogenesis, particularly with respect to hepatic
nofluorescence for YM1/YM2 (A) and MMR protein (B) in the lung of a
se 3 days post Lm infection. YM1/YM2–positive crystals are present within
f macrophages and multinucleated cells (original magnification, 400).
esentative of five each genotype examined. Splenocyte cultures from Lm-
ere incubated for 5 hours with 1 mol/L OVA323–339 and/or OVA257–264
4 and CD8 T lymphocyte stimulation, respectively. Monensin was added for
of culture, and the percentage of CD4 or CD8 lymphocytes expressing
ined by flow cytometry (C). Data are mean ( SEM) of six individual mice
te experiments with 3 of each genotype/experiment. *P  0.043.
Figure 7. Enhanced survival of gp91phox/ mouse recipients of
p47phox/ AAMacs. A: gp91phox/ Mouse survival after adoptive transfer
of 10  106 Lm or thioglycolate (TGCL)) elicited p47phox/ inflammatory
macrophages before Lm infection. PBS indicates survival of gp91phox/
control recipients that received PBS by i.v. injection. n  10 per group. P 
phox/6. Immu
/ mou
plasm o
are repr
mice w
for CD
2 hours
determ
o separa0.048. B: Tissue severity scores for gp91 recipients of Lm or TGCL
elicited p47phox/ inflammatory macrophages. n  5 per group. *P  0.05.
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mice.
Discussion
A physiological aim of inflammation is to restore tissue
homeostasis.1 However, cancer, autoimmunity, and ac-
tive inflammatory disease in immunodeficiency each
pose distinct tissue insults that drive chronic inflammation
that is not restorative. Furthermore, persistent insults can
alter the function of inflammatory mediators and effectors,
which include macrophages and T cells. During cell-
mediated immune responses, TH1-derived IFN- and
pathogen recognition receptor activation prime macro-
phages to become classically activated. These macro-
phages produce reactive oxygen and nitrogen interme-
diates to facilitate their microbicidal function, secrete
pro-inflammatory cytokines, and can be tumoricidal.3,5 In
contrast, TH2-driven pathogenesis and TH2-derived IL-4
and/or IL-13 adaptive immune responses, and local tis-
sue injury, induce alternative macrophage activation.
These macrophages promote wound healing and inhibit
pro-inflammatory cytokine production.3,5 We also show,
for what we believe is the first time, that p47phox/ and
gp91phox/ CGD mice develop distinct acute, innate
cellular responses and granulomatous inflammation in
response to Lm infection. Although both Lm-infected
CGD mice develop granulomatous inflammation, the ex-
tent and severity of pathology observed differ between
the two strains. We show that during acute primary Lm
infection, gp91phox/mice develop an aggressive gran-
ulomatous influx with necrotizing lesions in the liver and
spleen, whereas Lm-infected p47phox/ mice develop
less severe granulomatous inflammation in lung and
spleen, without evidence of necrosis.
Abscess and granuloma formation are characteristic
CGD defense reactions to infection with pathogens that
are typically eliminated by ROS. In addition, both lesions
cause local tissue injury. However, our investigations
reveal that the CGD knockout mouse inflammatory re-
sponse to acute sublethal Lm infection is different. Al-
though the acute granulomatous lesions in the
p47phox/ mice accumulate large numbers of Ym1
AAMacs, the gp91phox/mouse lesions are more typical
of those seen in IFN-– and tumor necrosis factor––
driven suppurative granulomas that are a hallmark of
chronic Lm infection.24–26 The finding of such dramati-
cally disparate acute tissue reactions in the CGD mice
strongly suggests that there is a cell-intrinsic basis for the
observed enhanced AAMac differentiation in p47phox/
macrophages. Indeed, we discerned that unlike WT or
gp91phox/ macrophages, p47phox/ macrophages
are hyperresponsive to IL-4 stimulation. Relative to both
WT and gp91phox/ macrophages, STAT6 activation
and STAT6 specific transcripts were significantly upregu-
lated in p47phox/ macrophages at lower doses of IL-4.
Moreover, restoring p47phox protein function corrected
the aberrant IL-4 driven p47phox/ AAMac phenotype,
which suggests that p47phox protein regulates IL-4 sig-
naling upstream of STAT6 activation.Potential regulatory mechanisms for p47phox protein
upstream of STAT6 are not entirely clear. A previous
report showed an association between p47phox and the
IL-4R  in Epstein–Barr virus–transformed human B
cells.27 Interestingly, preliminary investigations revealed
that p47phox co-immunoprecipitates with the IL-4R- in
Raw264 monocyte-macrophage cells. Therefore, future
studies will be extended to primary macrophages once
high-affinity antibodies are available for comprehensive
analyses of IL-4–induced protein–protein interactions
that involve the p47phox protein.
CGD is a multifaceted clinical disease and a unique
model of host immune defense. The genetically engi-
neered murine models of the most common genetic vari-
ants of CGD6,14 each recapitulate that the phagocyte
respiratory burst is critical for combating microbial infec-
tion. Furthermore, these models allow complex analyses
of innate and adaptive immune responses that are not
possible in human CGD patients. In addition, the murine
model can also be used to assess whether p47phox, the
essential adaptor protein for Nox2-dependent ROS activ-
ity, functions independently of the catalytic gp91phox/
Nox2 subunit, and to investigate clinical consequences
of p47phox protein deficiency. Although it has been re-
ported that IL-4 induced Nox1 and Nox5-dependent
ROS,28 our investigations showed that STAT6 activation
and target transcripts are similar in IL-4–stimulated WT
and gp91phox/ macrophages. In addition, neither
gp91phox/ nor Nox1-deficient macrophages hyperpro-
duced signature AAMac proteins in response to IL-4
stimulation, as observed in p47phox/ macrophages.
Collectively, these findings indicate that p47phox works
independent of the gp91phox/Nox2 catalytic subunit to
attenuate IL-4–stimulated macrophage activation. Con-
sistent with our observations, recent investigations have
revealed that, independent of its role in generating Nox2-
dependent ROS, p47phox is an important protein for inte-
grating signaling downstream of TLR9 in murine dendritic
cells.29
Granulomas are organized microenvironments that
provide physical barriers to contain pathogens that es-
cape from macrophages that are incompetent because
of protein dysfunction or microbial manipulation. Al-
though granulomas are controlled inflammatory sites,
they are also dynamic structures composed of active
effector cells that also cause tissue injury. An early, innate
response to tissue injury is mast cell– and basophil-de-
rived IL-4 production,3,30 which could drive the AAMac
differentiation observed in both CGD mice during acute
Lm infection, albeit by different mechanisms. The AAMac
phenotype in Lm-infected gp91phox/ mice could be
explained by tissue IL-4 production in response to exten-
sive tissue damage and necrosis. In contrast, although
there is a relative lack of tissue necrosis in Lm-infected
p47phox/ mice, consistent with the CGD phenotype,
these mice develop abscesses that cause tissue injury
and can thereby trigger local IL-4 production. Therefore,
the exaggerated AAMac phenotype in Lm-infected
p47phox/ mice could be explained by the p47phox/
macrophage predisposition to hyperrespond to IL-4 pro-
duced in the damaged tissues.
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they could develop severe, spontaneous systemic infec-
tion with granulomatous inflammation. Furthermore, we
also reported that the tissues from the spontaneous le-
sion in the p47phox/ mice contained variable amounts
of granuloma, abscess, and infection.6 Subsequently, we
demonstrated that these mice developed granulomatous
inflammation without infection.7 In this report, using a
controlled acute infection model, we now show that with
low-level bacterial stimulation, during the acute phase of
Lm infection, the p47phox/ mice develop granuloma-
tous inflammation with AAMacs. In addition, our current
findings suggest that these AAMacs also convey a rela-
tive protection. In conclusion, using histological analysis
as well as ex vivo molecular and cellular investigations,
we report a novel mechanism by which p47phox/ mice
develop extensive, systemic alternative macrophage ac-
tivation. These findings allow broader speculation about
the basis for the nonrestorative chronic inflammation that
is observed in CGD patients, and may explain why clin-
ical disease in X-linked CGD patients can be more severe
than in autosomal recessive CGD patients.16
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